Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Beckles

Thoracic Surgery (Cardiothoracic Vascular Surgery) Lake Charles, LA Medical Doctor

NPI 1548464837 CMS profile 116078

401 Dr Michael Debakey Dr, Lake Charles, LA 70601

Open in the dashboard

General payments

$79,526

273 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Daniel Beckles of Lake Charles, LA is reported in the CMS Open Payments database as having received $79,526 across 273 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,145 15
2024 General $9,170 45
2023 General $9,768 27
2022 General $10,611 35
2021 General $13,511 52
2020 General $9,490 18
2019 General $23,831 81

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Beckles
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Daniel Beckles were reported at $3,145. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Daniel Beckles Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $23,831 $886 $178–$3,167 $163
2020 $9,490 $341 $108–$1,605 $114
2021 $13,511 $453 $125–$1,886 $132
2022 $10,611 $695 $180–$2,566 $149
2023 $9,768 $745 $205–$2,662 $160
2024 $9,170 $799 $214–$2,967 $164
2025 $3,145 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CHF Solutions, Inc $50,848 53 payments
  2. Intuitive Surgical, Inc. $8,959 29 payments
  3. Edwards Lifesciences Corporation $5,981 27 payments
  4. Atricure, Inc. $3,846 28 payments
  5. Abbott Laboratories $2,482 27 payments
  6. Abiomed $1,368 19 payments
  7. Biotronik Inc. $1,256 13 payments
  8. Becton, Dickinson and Company $838 2 payments
  9. Medtronic, Inc. $752 18 payments
  10. Medistim USA, Inc. $441 8 payments
  11. Other $2,756 49 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $24,437 211 payments
  2. Consulting Fee $16,650 8 payments
  3. Travel and Lodging $13,806 44 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,804 1 payment
  5. Honoraria $6,700 2 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $5,614 3 payments
  7. Education $5,500 3 payments
  8. Gift $15 1 payment
Products named General payments · program years 2019–2025
  1. AQUADEX SMARTFLOW CONSOLE $26,809 29 payments
  2. Aquadex $24,039 24 payments
  3. DAVINCI XI $5,500 3 payments
  4. Da Vinci Surgical System $3,459 26 payments
  5. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $2,605 16 payments
  6. Carpentier-Edwards PERIMOUNT Magna Mitral Ease Pericardial Valve $1,993 6 payments
  7. Mitra Clip system $1,687 16 payments
  8. Impella $1,252 18 payments
  9. EDWARDS INTUITY Elite valve system $1,223 2 payments
  10. ATRICLIP LAA EXCLUSION SYSTEM $1,057 8 payments
  11. Other $10,458 146 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$88,616

Medicare's payments for the services billed

Medicare patients

103

Average age 75

Services billed

243

45 women, 58 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 63%
Atrial fibrillation 50%
Arthritis 50%
Diabetes 36%
Chronic kidney disease 33%
Depression 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
KEYTRUDA
  • Merck Sharp & Dohme Corporation $115
$115 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

273 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record